← back to search

Eric Lis

Memorial Sloan Kettering Cancer Center · US
Area of research
Surgery · Pathology and Forensic Medicine
Research interest
Research interests include Management of metastatic bone disease, Spinal Fractures and Fixation Techniques, Spine and Intervertebral Disc Pathology, and Brain Metastases and Treatment.
h-index
46
citations
8,703
works
183
NIH funding
primary concept
email

Recent publications

Detection of Osseous Spinal Metastasis with T1-Weighted Dynamic Contrast-Enhanced MRI and <sup>18</sup>F-FDG PET/CT: Assessing Agreement in Biopsy Proven Cases.
2026cited by 0position: contributordoi
Comprehensive Review of the Utility of Dynamic Contrast-Enhanced MRI for the Diagnosis and Treatment Assessment of Spinal Benign and Malignant Osseous Disease.
2025cited by 4position: contributordoi
Radiation Myelitis Risk After Hypofractionated Spine Stereotactic Body Radiation Therapy
JAMA Oncology 2024cited by 10position: middledoi
T1-Weighted, Dynamic Contrast-Enhanced MR Perfusion Imaging Can Differentiate between Treatment Success and Failure in Spine Metastases Undergoing Radiation Therapy.
2023cited by 1position: contributordoi
Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer
International Journal of Radiation Oncology*Biology*Physics 2021cited by 116position: middledoi
Survival Trends After Surgery for Spinal Metastatic Tumors: 20-Year Cancer Center Experience
Neurosurgery 2020cited by 87position: middledoi
Survival Trends After Surgery for Spinal Metastatic Tumors: 20-Year Cancer Center Experience
Neurosurgery 2020cited by 74position: contributordoi
Immunologic Correlates of the Abscopal Effect in a SMARCB1/INI1-negative Poorly Differentiated Chordoma after EZH2 Inhibition and Radiotherapy
Clinical Cancer Research 2019cited by 75position: middledoi
Integrating Evidence-Based Medicine for Treatment of Spinal Metastases Into a Decision Framework: Neurologic, Oncologic, Mechanicals Stability, and Systemic Disease
Journal of Clinical Oncology 2017cited by 166position: middledoi
Frequency of symptomatic vertebral body compression fractures requiring intervention following single-fraction stereotactic radiosurgery for spinal metastases
Neurosurgical FOCUS 2017cited by 56position: middledoi
Hybrid surgery–radiosurgery therapy for metastatic epidural spinal cord compression: A prospective evaluation using patient-reported outcomes
Neuro-Oncology Practice 2017cited by 56position: middledoi
Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group
The Lancet Oncology 2015cited by 247position: middledoi
Short-segment percutaneous pedicle screw fixation with cement augmentation for tumor-induced spinal instability
The Spine Journal 2015cited by 133position: middledoi
Five-Year Outcomes of High-Dose Single-Fraction Spinal Stereotactic Radiosurgery
International Journal of Radiation Oncology*Biology*Physics 2015cited by 94position: middledoi
The NOMS Framework: Approach to the Treatment of Spinal Metastatic Tumors
The Oncologist 2013cited by 878position: middledoi
Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients
Journal of Neurosurgery Spine 2013cited by 514position: middledoi
The incidence and patterns of hardware failure after separation surgery in patients with spinal metastatic tumors
The Spine Journal 2013cited by 122position: middledoi
International Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition in Spinal Stereotactic Radiosurgery
International Journal of Radiation Oncology*Biology*Physics 2012cited by 610position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mark H. Bilsky · Memorial Sloan Kettering Cancer Center14 papers (2012–2024)Yoshiya Yamada · Memorial Sloan Kettering Cancer Center13 papers (2012–2024)Ilya Laufer · NYU Langone Health9 papers (2013–2020)Anne S. Reiner · Memorial Sloan Kettering Cancer Center4 papers (2013–2020)Ori Barzilai · Palo Alto Institute4 papers (2017–2024) · 4 papers (2020–2026)Lily McLaughlin · Georgetown University4 papers (2015–2017)Adam M. Schmitt · Memorial Sloan Kettering Cancer Center3 papers (2017–2024)Daniel S. Higginson · Memorial Sloan Kettering Cancer Center3 papers (2017–2024)Brett Cox · Rush University Medical Center3 papers (2012–2013)Sasan Karimi · Memorial Sloan Kettering Cancer Center3 papers (2023–2026)Atin Saha · Memorial Sloan Kettering Cancer Center3 papers (2023–2026)Andrei Holodny · Memorial Sloan Kettering Cancer Center3 papers (2023–2026)Onur Yildirim · Memorial Sloan Kettering Cancer Center3 papers (2023–2026)K.K. Peck · University of Nottingham3 papers (2023–2026)Talia Chapman · Columbia University2 papers (2013–2013)Jason P. Sheehan · University of Virginia2 papers (2012–2015)Eric L. Chang · Keck Hospital of USC2 papers (2012–2015)Peter C. Gerszten · University of Pittsburgh2 papers (2012–2015)J. Bryan Iorgulescu · Broad Institute2 papers (2013–2013)